These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18031423)

  • 41. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Marchand K; Peachey GS; Westfall J; Lock K; MacDonald S; Jun J; Bojanczyk-Shibata A; Harrison S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):68. PubMed ID: 34530878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials.
    Pérez-Mañá C; Castells X; Vidal X; Casas M; Capellà D
    J Subst Abuse Treat; 2011 Mar; 40(2):109-22. PubMed ID: 21036508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulant use in suicides: A systematic review.
    Mantinieks D; Schumann J; Drummer OH; Woodford NW; Gerostamoulos D
    Forensic Sci Int; 2022 Sep; 338():111391. PubMed ID: 35908335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective drug therapy for cocaine dependence: a milestone.
    Dürsteler KM; Vogel M
    Lancet; 2016 May; 387(10034):2171-3. PubMed ID: 27015910
    [No Abstract]   [Full Text] [Related]  

  • 46. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining the effectiveness of acetylcholinesterase inhibitors and stimulant-based medications for cognitive dysfunction in multiple sclerosis: A systematic review and meta-analysis.
    Cotter J; Muhlert N; Talwar A; Granger K
    Neurosci Biobehav Rev; 2018 Mar; 86():99-107. PubMed ID: 29406017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.
    Regier PS; Kampman KM; Childress AR
    Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach.
    Tardelli VS; Berro LF; Gerra G; Tadonio L; Bisaga A; Fidalgo TM
    Addict Biol; 2023; 28(4):e13271. PubMed ID: 37016755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treating cocaine addiction].
    Herdener M; Oppliger R; Stohler R; Caflisch C
    Praxis (Bern 1994); 2012 Aug; 101(16):1013-9. PubMed ID: 22878944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation.
    Schmitz JM; Rathnayaka N; Green CE; Moeller FG; Dougherty AE; Grabowski J
    Front Psychiatry; 2012; 3():77. PubMed ID: 22969732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive treatment with psychostimulants and stimulant-like drugs for resistant bipolar depression: a systematic review and meta-analysis.
    Tsapakis EM; Preti A; Mintzas MD; Fountoulakis KN
    CNS Spectr; 2020 Jul; ():1-12. PubMed ID: 32641179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responding to global stimulant use: challenges and opportunities.
    Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R
    Lancet; 2019 Nov; 394(10209):1652-1667. PubMed ID: 31668409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological treatment of apathy in neurodegenerative diseases: a systematic review.
    Drijgers RL; Aalten P; Winogrodzka A; Verhey FR; Leentjens AF
    Dement Geriatr Cogn Disord; 2009; 28(1):13-22. PubMed ID: 19609082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulant sensitization in humans.
    Gorelick DA; Rothman RB
    Biol Psychiatry; 1997 Aug; 42(3):230-1. PubMed ID: 9232217
    [No Abstract]   [Full Text] [Related]  

  • 56. Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity.
    Richards JR; Gould JB; Laurin EG; Albertson TE
    Clin Exp Emerg Med; 2019 Mar; 6(1):84-88. PubMed ID: 29381909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexamphetamine treatment in stroke.
    Long D; Young J
    QJM; 2003 Sep; 96(9):673-85. PubMed ID: 12925723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.
    Stoops WW; Rush CR
    Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CNS or classic drugs for the treatment of pain in functional dyspepsia? A systematic review and meta-analysis of the literature.
    Passos Mdo C; Duro D; Fregni F
    Pain Physician; 2008; 11(5):597-609. PubMed ID: 18850025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The treatment of stimulant dependence.
    Schuckit MA
    Addiction; 1994 Nov; 89(11):1559-63. PubMed ID: 7841871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.